Amelia Schirmer

Amelia Schirmer, PhD, is a Senior Scientist specializing in In Vivo Pharmacology at SpringWorks Therapeutics since May 2023, where responsibilities include leading biology and assay development for pipeline projects, alongside presenting groundbreaking research at international symposiums. Prior to this role, Amelia served as a doctoral candidate in the Pathology Department at Duke University from August 2018 to May 2023, focusing on molecular pathology and cancer research. Additional positions at Duke involved administrative and teaching roles, contributing to graduate education. Earlier experience includes working as a Research Technician III at Charles River Laboratories and as a field technician at NEON, Inc. Amelia holds a PhD in Pathology/Experimental Pathology from Duke University and dual bachelor's degrees in Environmental Science from the University of North Carolina at Chapel Hill.